Anna Celeste Alonzi

Anna Celeste Alonzi is an experienced regulatory affairs professional with a focus on CMC for biologics and veterinary products. Currently serving as Associate Director at Novavax since October 2021, Anna previously held positions including Senior Manager, Regulatory Affairs CMC at Eli Lilly and Company, and Senior Regulatory Associate-Biologics at Genentech. Anna's expertise encompasses post-approval submissions, regulatory compliance, and managing CMC activities across multiple companies such as Pfizer and Johnson & Johnson. Educational qualifications include a Regulatory Affairs Certificate from RAPSOnline University, a Master’s degree in Nutrition, and a degree in Biological Sciences from Università degli Studi dell'Aquila. Active in professional circles as an AAPS member since 2016, Anna demonstrates a strong commitment to regulatory excellence in the pharmaceutical and biopharmaceutical industries.